Headache occurrence during the early stages of COVID-19 infection could be attributed to excess pro-inflammatory cytokine release, e.g., interleukin 1 (IL 1) and tumor necrosis factor-alpha (TNF-α), which promote trigeminal neural network sensitization, a key event in headache pathology [27]. This evidence concerns the gene TNF and Headache.